Prominent Diagnostics in Cellular Health Screening Market

Cellular health is of utmost importance since it directly impacts how an individual’s body functions, repairs itself, and how well it produces new body tissue. Besides, with six in ten Americans suffering from at least one chronic disease, as per the Centers for Disease Control and Prevention (CDC), cellular health screening is an indispensable part of routine medical check-ups. According to Inkwood Research, the global cellular health screening market is forecasted to grow with a CAGR of 9.32% during the estimated period of 2023 to 2032.

The surging geriatric population, as well as the increasing prevalence of chronic diseases, are among the primary factors influencing the growing demand for cellular health screening services. Also, the ongoing exploration & development activities broaden the spectrum of applications while improving screening accuracy and efficiency of cellular health screening services. Such activities facilitate technological developments and play an essential role in driving market growth.

Shaping the Future of Healthcare: Prominent & Next-Gen Diagnostics in Cellular Health Screening

• Cell Sorting Technology – Cell separation or sorting refers to the procedure of isolating specific cell populations from a biological sample, such as blood or tissue. Cell sorting enables scientists to isolate live, homogenous cell populations in order to answer critical questions associated with cellular changes taking place under particular conditions, cellular response to drugs, and stem cell

In February 2023, Thermo Fisher Scientific (United States) announced the launch of Bigfoot Spectral Cell Sorter in India. The first-of-its-kind cell sorting technique combines traditional sorting and analysis with spectral sorting, thus facilitating simple, high-speed cell sorting. The insights acquired via cell sorting are beneficial in genome editing, drug and toxicity screening, vaccine studies, as well as gene and cell therapy development.

• Preventive Healthcare & Early Disease Identification – Preventive healthcare, as well as early disease identification, are gaining significant traction for the timely diagnosis and treatment of various conditions. Cellular health screening, in this regard, has the potential to spot cellular alterations before the onset of symptoms, thus enabling proactive interventions and enhanced health outcomes. Some common screening tests include –

• Cholesterol Measurements: Cholesterol screening is performed by a blood test. Individuals with high cholesterol measurements from a blood sample have a greater risk for cardiovascular disease (CVD) compared to those with cholesterol within the normal range.As per Inkwood Research, blood is set to be the prominent type in the global cellular health screening market during the forecast period. By detecting elevated cholesterol levels early on, individuals can take proactive steps to manage their cholesterol and reduce the risk of developing heart-related complications.

• Pap Smears: Pap smears are crucial diagnostic tools for women. It entails the collection of cell samples from the cervix to detect cellular changes that may suggest the presence of cervical cancer. This screening test holds particular significance for sexually active women under the age of 65, as it allows for the detection of cancer at an early stage, even before symptoms are apparent.

• Personalized Medication – Personalized medicines, primarily in the field of cellular health screening, consider an individual’s unique biological characteristics. These include mitochondrial activity, inflammatory markers, oxidative stress levels, and telomere length. The bespoke method helps facilitate focused interventions and treatment programs suited to an individual’s precise cellular health requirements. With regard to cancer, for example, precision medicine most often entails the examination of how changes in certain proteins or genes within a person’s cancer cells impacts their care, including treatment options.

Accordingly, as per the American Cancer Society, precision medicine can be utilized for individuals at higher risk for developing certain malignancies. For instance, if a person’s family history indicates a pattern of cancer, doctors can utilize the screening information to lay out a plan of care or even make a more accurate diagnosis. In terms of preventative measures, these tests can help detect cancer early, while helping doctors prescribe personalized medicines or suggesting healthy habits that may help lower the person’s cancer risk.

Cellular health screening encourages the implementation of proactive interventions, lifestyle changes, and precision medicines in order to improve cellular function and general health. With more advancements and anticipated breakthroughs in screening technologies expected over the upcoming years, the global cellular health screening market is set to witness lucrative growth opportunities during the projection period.

By Shruti Vanjare